Budget Impact Vs Cost Effectiveness: Implications for Personalised Cancer Therapies
نویسندگان
چکیده
منابع مشابه
Rehabilitation for cancer survivors Cost-effectiveness and budget impact
Introduction: Many cancer survivors suffer from a combination of diseaseand treatment-related morbidities and complaints after primary treatment. There is a growing evidence base for the effectiveness of mono-dimensional rehabilitation interventions; in practice, however, patients often participate in multidimensional programs. This study systematically reviews evidence regarding effectiveness ...
متن کاملTherapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations.
OBJECTIVE To evaluate the cost-effectiveness of osteoporosis treatments for women at high fracture risk and estimate the population-level impact of providing bisphosphonate therapy to all eligible high-risk US women. STUDY DESIGN Fractures, healthcare costs, and quality-adjusted life-years (QALYs) were estimated over 10 years using a Markov model. METHODS No therapy, risedronate, alendronat...
متن کاملHow cancer patients value hope and the implications for cost-effectiveness assessments of high-cost cancer therapies.
Assessments of the medical and economic value of therapies in diseases such as cancer traditionally focus on average or median gains in patients' survival. This focus ignores the value that patients may place on a therapy with a wider "spread" of outcomes that offer the potential of a longer period of survival. We call such treatments "hopeful gambles" and contrast them with "safe bets" that of...
متن کاملCost-effectiveness of androgen suppression therapies in advanced prostate cancer.
BACKGROUND The costs and side effects of several antiandrogen therapies for advanced prostate cancer differ substantially. We estimated the cost-effectiveness of antiandrogen therapies for advanced prostate cancer. METHODS We performed a cost-effectiveness analysis using a Markov model based on a formal meta-analysis and literature review. The base case was assumed to be a 65-year-old man wit...
متن کاملEstablishing cost-effectiveness of genetic targeting of cancer therapies
Professor WH van Harten MD ment [2]. In 2002, researchers at the Netherlands Cancer Institute (NKI, Amsterdam, the Netherlands) identified a 70-gene prognosis signature (MammaPrintTM), using microarray analysis for lymph node-negative breast cancer patients [3]. Using the 70-gene signature, the selection of patients that will benefit most from adjuvant systemic treatment could be more accurate....
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2014
ISSN: 0923-7534
DOI: 10.1093/annonc/mdu308.2